leukemia/mds€¦ · leukemia/mds. 0 - not having . achieved remission. 1 - in remission. 2 - in...
TRANSCRIPT
HEMATOLOGY 1
© Copyright 2015; Revised 9/24/15
LEUKEMIA/MDS
0 - Not having achieved remission 1 - In remission 2 - In relapse
Leukemia,
LYMPHOID 0 - Acute lymphoblastic leukemia 1- Chronic lymphocytic leukemia of B-cell type 3 - Prolymphocytic leukemia of B-cell type 4 - Hairy cell leukemia 5 - Adult T-cell lymphoma/leukemia (HTLV-1-associated) 6 - Prolymphocytic leukemia of T-cell type A - Mature B-cell leukemia Burkitt-type Z - Other lymphoid leukemia 9 - Unspecified
C91.
Unspecified Malignant Neoplasms of
LYMPHOID, HEMATO POIETIC & RELATED TISSUE
0 - Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis 2 - Malignant mast cell tumor 4 - Sarcoma of dendritic cells (accessory cells) 5 - Multifocal and unisystemic Langerhans-cell histiocytosis 6 - Unifocal Langerhans-cell histiocytosis A - Histiocytic sarcoma Z - Other specified 9 - Unspecified
C96.
0 -Not having achieved remission 1 - In remission 2 - In relapse
Leukemia,
MYELOID
0 - Acute myeloblastic leukemia 1 - Chronic myeloid leukemia, BCR/ABL- positive 2 - Atypical chronic myeloid leukemia, BCR/ABL-negative 3 - Myeloid sarcoma 4 - Acute promyelocytic leukemia 5 - Acute myelomonocytic leukemia 6 -Acute myeloid leukemia with 11q23- abnormality A - Acute myeloid leukemia with multilineage dysplasia Z - Other myeloid leukemia 9 - Unspecified
C92.
0 - Acute monoblastic/monocytic leukemia 1 - Chronic myelomonocytic leukemia 3 - Juvenile myelomonocytic leukemia Z - Other monocytic leukemia 9 - Unspecified
0 - Not having achieved remission 1- In remission 2– In relapse
Leukemia,
MONOCYTIC C93.
Poisoning by Adverse Effect of & Underdosing of,
ANTINEOPLASTIC & IMMUNOSUPPRESSIVE DRUGS
1- Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional) 5- Adverse effect of antineoplastic & immunosuppressive drugs
A - initial encounter D - subsequent encounter S - sequela
T45.1X
0 - Not having achieved remission 1 - In remission 2 - In relapse
Other Leukemias of
SPECIFIED CELL TYPE 0 - Acute erythroid leukemia 2 - Acute megakaryoblastic leukemia 3 - Mast cell leukemia 4 - Acute panmyelosis with myelofibrosis 8 - Other specified leukemias
STOP 6 - Myelodysplastic disease, not classified
C94.
0 - Not having achieved remission 1- In remission 2– In relapse
C95. Leukemia of UNSPECIFIED CELL TYPE
0 - Acute 1 - Chronic 9 - Unspecified
MYELODYSPLASTIC SYNDROME (MDS)
0 - Not having achieved remission 1- 1 2– 2
2 - Refractory anemia with excess of blasts
STOP
Use T45.1X code for adverse effect, if applicable
D46.
0 - Refractory anemia without ring sideroblasts, so stated 1 - Refractory anemia with ring sideroblasts A - Refractory cytopenia with multilineage dysplasia B - Refractory cytopenia with multilineage dysplasia and ring sideroblasts C - Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality 4 - Refractory anemia, unspecified Z - Other myelodysplastic syndromes 9 - Unspecified
0 - Not having achieved remission 1 - In remission 2 – In relapse
Multiple Myeloma & Malignant
PLASMA CELL NEOPLASM
C90.
0 - Multiple Myeloma 1 - Plasma cell leukemia 2 - Extramedullary plasmacytoma 3 - Solitary plasmacytoma
HEMATOLOGY 2
© Copyright 2015; Revised 9/24/15
B-CELL LYMPHOMA
Lymphoma,
FOLLICULAR
0 - Unspecified site 1 - Head, neck, face 2 - Intrathoracic 3 - Intra-abdominal 4 - Axilla and upper limb 5 - Inguinal region and lower limb 6 -Intrapelvic 7 -Spleen 8 - Multiple-sites 9 - Extranodal and solid organ site
0 - Grade I 1 - Grade II 2 - Grade III unspecified 3 - Grade IIIa 4 - Grade IIIb 5 - Diffuse follicle center lymphoma 6 - Cutaneous follicle center lymphoma 8 - Other types lymphoma 9 - Unspecified
C82. Lymphomas, MALIGNANT IMMUNOPROLIFERATIVE & OTHER B-CELLS
0 - Waldenstrom macroglobulinemia 2 - Heavy chain disease 3 - Immunoproliferative small intestinal disease 4 - Extranodal marginal zone B-cell lymphoma of mucosa-
associated lymphoid tissue [MALT-lymphoma] 8 - Other malignant immunoproliferative diseases 9 - Unspecified.
C88.
Lymphoma,
HODGKIN 0 - Nodular lymphocyte predominant 1 - Nodular sclerosis classical 2 - Mixed cellularity classical 3 - Lymphocyte-depleted classical 4 - Lymphocyte-rich classical 7 - Other classical 9 - Unspecified
0 - Unspecified site 1 - Head, neck, face 2 - Intrathoracic 3 - Intra-abdominal 4 - Axilla and upper limb 5 - Inguinal region and lower limb 6 -Intrapelvic 7 -Spleen 8 - Multiple-sites 9 - Extranodal and solid organ site
C81.
Lymphoma,
NON-FOLLICULAR 0 - Unspecified site 1 - Head, neck, face 2 - Intrathoracic 3 - Intra-abdominal 4 - Axilla and upper limb 5 - Inguinal region and lower limb 6 -Intrapelvic 7 -Spleen 8 - Multiple-sites 9 - Extranodal and solid organ site
0 - Small cell B-cell Lymphoma 1 - Mantle cell Lymphoma 3 - Diffuse Large B-cell lymphoma 5 - Lymphoblastic (diffuse lymphoma) 7 - Burkitt lymphoma 8 - Other non-follicular Lymphoma (includes PEL/ intravascular) 9 - Unspecified
C83.
Lymphoma,
OTHER NON-HODGKIN
0 - Unspecified site 1 - Head, neck, face 2 - Intrathoracic 3 - Intra-abdominal 4 - Axilla and upper limb 5 - Inguinal region and lower limb 6 -Intrapelvic 7 -Spleen 8 - Multiple-sites 9 - Extranodal and solid organ site
1 - Unspecified B-cell lymphoma 2 - Mediastinal (thymic) large B-cell 8 - Other specified types of non-Hodgkin’s 9 - Unspecified
C85.
Lymphoma, Other
SPECIFIED T/NK-CELL 0 - Extranodal NK/T-cell lymphoma, nasal type 1 - Hepatosplenic T-cell lymphoma 2 - Enteropathy-type (intestinal) T-cell lymphoma 3 - Subcutaneous panniculitis-like-T-cell lymphoma 4 - Blastic NK-cell lymphoma 5 - Angiommunoblastic T-cell lymphoma 6 - Primary cutaneous CD-30-positive T-cell proliferations
C86.
HEMATOLOGY
© Copyright 2015; Revised 9/24/15
MYELOPROLIF/MGUS
0 - Histiocytic and mast cell tumors of uncertain behavior 1 - Chronic myeloproliferative disease 2 - Monoclonal gammopathy 3 - Essential (hemorrhagic) thrombocythemia 4 - Osteomyelofibrosis 9 - Unspecified
Neoplasms of Uncertain Behavior of
LYMPHOID, HEMA-TOPOIETIC & RELATED TISSUE
Z - Other specified neoplasms
1- Post-transplant lymphoproliferative disorder (PTLD) 9 - Other specified neoplasms
For MYELOFIBROSIS, use D75.81
D47.
STOP
POLYCYTHEMIA VERA
D45
MONOCLONAL GAMMOPATHY
D47.2
ESSENTIAL (HEMORRHAGIC) THROMBOCYTHEMIA
D47.3
0 - Familial erythrocytosis 1 - Secondary polycythemia 9 - Unspecified
Other & Unspecified Diseases of
BLOOD & BLOOD-FORMING ORGANS (MYELOFIBROSIS)
8 - Other specified diseases of blood and blood- forming organs
1- MYELOFIBROSIS (Code first underlying disorder such as neoplasm. If applicable, code for associated therapy-related MDS and for adverse effects to identify drug) 2 - Heparin induced thrombocytopenia (HIT) 9 - Other specified diseases of blood and blood-forming organs
STOP
D75.
0 - Secondary to blood loss (chronic) 1 - Sideropenic dysphagia 8 - Other iron deficiency anemias 9 - Unspecified
Anemia,
IRON DEFICIENCY D50.
Anemia, VITAMIN B12 DEFICIENCY 0 - Intrinsic factor deficiency 1 - Selective vitamin B12 malabsorption with proteinuria 2 - Transcobalamin II deficiency 3 - Other dietary Vitamin B12 deficiency 8 - Other 9 - Unspecified
D51.
Anemia,
FOLATE DEFICIENCY 0 –Dietary 1 - Drug-induced (Use additional code for adverse effects, if applicable, to identify drug) 8 - Other 9 - Unspecified
D52.
Anemias,
OTHER NUTRITIONAL 0 - Protein deficiency anemia 1 - Other megaloblastic anemias, not elsewhere classified 2 - Scorbutic anemia 8 - Other 9 - Unspecified
D53.
NUTRITIONAL ANEMIAS
MYELOFIBROSIS D75.81
IRON OVERLOAD & OTHERS
0 - Disorder of Iron Metabolism, unspecified
0 - Hereditary 1 - Due to repeated red blood cell transfusions 8 - Other 9 - Unspecified
STOP
1 - Hemochromatosis
E83.1
HEMATOLOGY 4
© Copyright 2015; Revised 9/24/15
OTHER ANEMIAS
0 - Due to glucose-6-phosphate dehydrogenase [G6PD] deficiency 1 - Other disorders of glutathione metabolism 2 - Disorders of glycolytic enzymes 3 - Disorders of nucleotide metabolism 8 - Other anemias 9 - Unspecified
Anemia due to
ENZYME DISORDERS D55.
D59. Hemolytic Anemia,
ACQUIRED
0 -Drug-induced autoimmune (Use additional code for adverse effects, if applicable, to identify drug) 1 - Other autoimmune 2 - Drug-induced non-autoimmune (Use additional code for adverse effects, if applicable, to identify drug) 3 - Hemolytic-uremic syndrome (Use additional code to identify associated: E. coli, Pneumoncoccal pneumonia, or Shigella dysenteriae) 4 - Other non-autoimmune 5 - Paroxysmal nocturnal hemoglobinuria (Marchiafava-Micheli) 6 - Hemoglobinuria due to hemolysis from other external causes 8 - Other acquired hemolytic anemias 9 - Unspecified
0 –Alpha 1 - Beta 2 - Delta-beta 3 - Minor 4 - HPFH (Hereditary persistence of fetal hemoglobin) 5 - Hemoglobin E-beta 8 - Other 9 - Unspecified
THALASSEMIA D56.
SICKLE CELL DISORDERS
0 - Without crisis
1 - Acute chest syndrome
2 - Splenic sequestration
9 - Unspecified
1 - Sickle cell without crisis 3 - Sickle-cell trait
0 - Hb-SS with crisis
2 - Hb-C disease 4 - Thalassemia 8 - Other Sickle-Cell
1 - With crisis
STOP
Use additional code for any associated fever
STOP
STOP
D57.
0 - Unspecified 1 - Acute chest syndrome 2 - Splenic sequestration
1 - Drug-induced aplastic anemia (If applicable, use additional code for adverse effects to identify drug) 2 - Aplastic anemia due to other external agents (If applicable, code first toxic effects of substance chiefly non-medicinal as to source (T51-T65) 3 - Idiopathic aplastic anemia 9 - Unspecified
Other Aplastic Anemias & Other BONE MARROW FAILURE SYNDROMES
1 - Constitutional (pure) red blood cell aplasia 9 - Other constitutional aplastic anemia
0– Constitutional aplastic anemia
1- Pancytopenia
0 - Antineoplastic chemotherapy induced
pancytopenia 1 - Other drug-induced
pancytopenia 8 - Other pancytopenia
2 - Myelophthisis 9- Other specified aplastic anemias
& other bone marrow failure
syndrome
8 - Other specified aplastic anemias & other bone marrow failure syndromes
STOP
STOP
D61.
0 - Anemia in neoplastic disease (Code first neoplasm) 1 - Anemia in chronic kidney disease (Code first underlying CKD) 8 - Anemia in other chronic diseases classified elsewhere (Code first underlying disease such as: - Hypothyroidism - Tuberculosis)
Anemia in
CHRONIC DISEASES CLASSIFIED ELSEWHERE
D63.
0 - Hereditary sideroblastic anemia 1 - Secondary sideroblastic anemia due to disease 2 - Secondary sideroblastic anemia due to drugs and toxins 3 - Other sideroblastic anemias 4 - Congenital dyserythropoietic anemia 9 - Unspecified
OTHER ANEMIAS
8 –Other specified anemias
1- Anemia due to anti-neoplastic chemotherapy 9 -Other specified anemias
STOP
D64.
HEMATOLOGY 5
© Copyright 2015; Revised 9/24/15
NEUTROPENIA & OTHER WBC DISORDERS
Functional Disorders of
POLYMORPHONUCLEAR NEUTROPHILS
D71
MYELOFIBROSIS, HLH, HIT, 2° POLYCYTHEMIA
0 – Congenital agranulocytosis 1 - Agranulocytosis secondary to cancer chemotherapy (Code also underlying neoplasm. Use additional code for adverse effect, if applicable, to identify drug.) 2 - Other drug-induced agranulocytosis (Use additional code for adverse effect, if applicable, to identify drug) 3 - Neutropenia due to infection 4 - Cyclic neutropenia 8 - Other 9 - Unspecified
NEUTROPENIA
Use additional code for any associated fever & mucositis
D70.
0 - Familial erythrocytosis 1 - Secondary polycythemia 9 - Unspecified
Other & Unspecified Diseases of
BLOOD & BLOOD-FORMING ORGANS (MYELOFIBROSIS)
8 - Other specified diseases of blood and blood- forming organs
1- MYELOFIBROSIS (Code first underlying disorder such as neoplasm. If applicable, code for associated therapy-related MDS and for adverse effects to identify drug) 2 - Heparin induced thrombocytopenia (HIT) 9 - Other specified diseases of blood and blood-forming organs
STOP
D75. Other Specified Diseases
W/Participation of
LYMPHORETICULAR & RETICULOHISTIOCYTIC TISSUE 1 - Hemophagocytic lymphohistiocytosis 2 - Hemophagocytic syndrome, infection-associated (Use additional code to identify infectious agent or disease) 3 - Other histiocytosis syndromes
D76.
0 - Lymphocytopenia 8 - Other 9 - unspecified
0 - Lymphocytosis (symptomatic)
1 - Monocytosis (symptomatic)
2 - Plasmacytosis 3 - Leukemoid reaction 4 - Basophilia 5 - Bandemia 8 - Other 9 - Unspecified
Other Disorders of
WHITE BLOOD CELLS
8 - Other
specified disorders
of white blood cells
0 - Genetic anomalies of leukocytes 1 - Eosinophilia 9 - Unspecified
1 - Decreased white blood cell count
2 - Elevated white blood cell count
9 - Other specified disorders
STOP
STOP
D72.
HEMATOLOGY 6
© Copyright 2015; Revised 9/24/15
HEPATIC THROMBOSIS
I81: PORTAL VEIN THROMBOSIS
I82.0: BUDD-CHIARI SYNDROME
NONPYOGENIC THROMBOSIS OF INTRACRANIAL VENOUS SYSTEM
I67.6
ACUTE EMBOLISM & THROMBOSIS OF DEEP VEINS OF LOWER EXTREMITY 0 - Unspecified deep veins/ lower extremity 1 - Femoral vein 2 - Iliac vein 3 - Popliteal vein 4 - Tibial vein 9 - Other specified Y - Proximal lower extremity Z - Distal lower extremity
1 - Right 2 - Left 3 - Bilateral 9 - Unspecified
I82.4
POSTTHROMBOTIC SYNDROME 0 - Without complications 1 - With ulcer 2 - With inflammation 3 - With ulcer & inflammation 9 - With other complications
1 - Right lower extremity 2 - Left lower extremity 3 - Bilateral lower extremity 9 - Unspecified lower extremity
I87.0
PULMONARY EMBOLISM W/O ACUTE COR PULMONALE
0 - Septic pulmonary embolism 2 - Saddle embolus of pulmonary artery 9 - Other
I26.9
Other
COAGULATION DEFECTS 0 - Von Willebrand's disease 1- Hereditary factor XI deficiency 2 -Hereditary deficiency of other clotting factors 4 - Acquired coagulation factor deficiency 8 - Other specified coagulation defects 9 - Unspecified
D68.
Hemorrhagic Disorders due to
CIRCULATING ANTI-COAGULANTS 3 - Hemorrhagic
disorder due to circulating anticoagulants
1- Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
2 - Hemorrhagic disorder due to extrinsic
circulating anticoagulants
1 - Acquired hemophilia 2 - Antiphospholipid
antibody with hem-orrhagic disorder
8 - Other Hemorrhagic disorder due to intrinsic circulat- ing anticoagulants, antibodies, or inhibitors
STOP
D68.
1- Activated protein C resistance 2 - Prothrombin gene mutation 9 - Other primary thrombophilia
5 - Primary thrombophilia
6 - Other thrombophilia
1- Antiphospholipid syndrome 2 - Lupus anticoagulant syndrome 9 - Other thrombophilia
D68. Other Coagulation Defects,
THROMBOPHILIA
D75.82 HEPARIN INDUCED THROMBOCYTOPENIA
HEMATOLOGY 8
© Copyright 2015; Revised 9/24/15
0 - Wiskott-Aldrich syndrome 1 - Di George's syndrome 2 -Immunodeficiency with short-limbed stature 3 -Immunodeficiency following hereditary defective response to Epstein-Barr virus 4 -Hyperimmunoglobulin E [IgE] syndrome 8 - Other specified major defects 9 - Unspecified
D82. Immunodeficiency associated with
OTHER MAJOR DEFECTS
COMMON VARIABLE IMMUNODEFICIENCY
0 - With predominant abnormalities of B-cell numbers and function 1 - With predominant immunoregulatory T-cell disorders 2 -With autoantibodies to B- or T-cells 8 - Other common variable immunodeficiency 9 -Unspecified
D83.
STOP
9 - Other combined immuno- deficiencies
8 - Other combined immuno-
deficiencies
1 - Biotin-dependent carboxylase deficiency
0 - Biotinidase deficiency 8 - Other biotin- dependent carboxylase Deficiency 9 - Unspecified
COMBINED IMMUNODEFICIENCIES
0 - Severe combined immunodeficiency [SCID] with reticular dysgenesis 1 - SCID with low T- and B-cell numbers 2 - SCID with low or normal B-cell numbers 3 - Adenosine deaminase [ADA] deficiency 4 - Nezelof's syndrome 5 - Purine nucleoside phosphorylase [PNP] deficiency 6 - Major histocompatibility complex class I deficiency 7 - Major histocompatibility complex class II deficiency 9 - Unspecified
STOP
D81.
0 - Acute 1 - Chronic 2 -Acute on chronic graft- versus-host disease 3 - Unspecified
2 - Autoimmune lymphoproliferative syndrome [ALPS] 9 - Other specified disorders
Other Disorders Involving the
IMMUNE MECHANISM, NOT ELSEWHERE CLASSIFIED
8 - Other specified disorders involving the immune
mechanism, not elsewhere classified
0 - Polyclonal hypergammaglobulinemia 1 - Cryoglobulinemia 2 - Hypergammaglobulinemia, unspecified 3 - Immune reconstitution syndrome 9 - Unspecified
1 - Graft-versus-host disease
D89.
STOP
STOP
GRAFT-VERSUS-HOST DISEASE
0 - Acute 1 - Chronic 2 - Acute on chronic 3 - Unspecified
D89.81
1 - Right lacrimal gland 2– Left lacrimal gland 3 - Bilateral lacrimal glands 9 - Unspecified lacrimal gland
DRY EYE SYNDROME HO4.12
0 - Localized 1 - Generalized
ENLARGED LYMPH NODES
R59.
9
© Copyright 2015; Revised 9/24/15
DRUG-INDUCED PHENOMENON
D70.1 AGRANULOCYTOSIS SECONDARY TO CANCER CHEMOTHERAPY
OTHER SECONDARY THROMBOCYTOPENIA
D69.59
* Due to drugs, EtOH, alloimmunization; NOT ITP
DRUG (OPIATE) INDUCED CONSTIPATION
K59.09
ANEMIA DUE TO ANTINEOPLASTIC CHEMOTHERAPY
D64.81
DRUG-INDUCED CUSHING'S SYNDROME
E24.2 DRUG-INDUCED ADRENOCORTICAL INSUFFICIENCY
E27.3
STOP 0 - With cholestasis 2 - With acute hepatitis
TOXIC LIVER DISEASE
0 - Without coma 1 -With coma
1 - With hepatic necrosis
This is for toxic effects due to drug; Does Not include ETOH
K71.
0 - Drug-induced 1 - Alcoholic 2 - Due to other toxic agents 9 - Unspecified (as used for AIDS)
Other & Unspecified POLYNEUROPATHIES
1 -Critical illness 2 - Radiation-induced 9 - Other
8 - Other specified
STOP
G62.
ORAL MUCOSITIS, ULCERATIVE
0 -Unspecified 1 - Due to antineoplastic therapy 2 - Due to other drugs 3 - Due to radiation 9 - Other
K12.3
POLYNEUROPATHY IN DISEASES CLASSIFIED ELSEWHERE (Includes myeloma induced neuropathy)
G63
DRUG-INDUCED PHENOMENON
DRUG (OPIATE) INDUCED CONSTIPATION
K59.09
AGRANULOCYTOSIS DUE TO NON-CHEMOTHERAPY DRUG
D70.2